A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.
All Keywords
【저자키워드】 COVID-19, Serosurvey, Greece, SARS-CoV-2 IgG antibodies, 【초록키워드】 SARS-CoV-2, Seroprevalence, Infection, Prevalence, IgG antibody, Measures, sera, Effectiveness, COVID-19 incidence, Older, individual, Fatality rate, positive, females, Respiratory Coronavirus, was performed,
【저자키워드】 COVID-19, Serosurvey, Greece, SARS-CoV-2 IgG antibodies, 【초록키워드】 SARS-CoV-2, Seroprevalence, Infection, Prevalence, IgG antibody, Measures, sera, Effectiveness, COVID-19 incidence, Older, individual, Fatality rate, positive, females, Respiratory Coronavirus, was performed,